Baader Bank Aktiengesellschaft boosted its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 50.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,635 shares of the company’s stock after purchasing an additional 1,217 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Colgate-Palmolive were worth $330,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Reston Wealth Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at approximately $42,000. Capital Performance Advisors LLP bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $53,000. Prospera Private Wealth LLC bought a new position in Colgate-Palmolive in the third quarter worth $64,000. Finally, True Wealth Design LLC boosted its position in shares of Colgate-Palmolive by 1,460.9% during the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after acquiring an additional 672 shares in the last quarter. 80.41% of the stock is owned by institutional investors.
Colgate-Palmolive Stock Up 1.5 %
NYSE:CL opened at $90.96 on Friday. The stock’s fifty day simple moving average is $91.58 and its 200-day simple moving average is $97.29. The firm has a market capitalization of $74.31 billion, a P/E ratio of 26.06, a P/E/G ratio of 3.59 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30.
Colgate-Palmolive Announces Dividend
Insider Activity at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.34% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on the company. UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. Finally, Barclays reduced their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus target price of $102.00.
Get Our Latest Research Report on CL
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- When to Sell a Stock for Profit or Loss
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is a SEC Filing?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is MarketRank™? How to Use it
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.